首页> 外文OA文献 >Effi cacy and safety of re-treatment with the sameudartemisinin-based combination treatment (ACT) comparedudwith an alternative ACT and quinine plus clindamycin afterudfailure of fi rst-line recommended ACT (QUINACT): a bicentre,udopen-label, phase 3, randomised controlled trial

【2h】

Effi cacy and safety of re-treatment with the sameudartemisinin-based combination treatment (ACT) comparedudwith an alternative ACT and quinine plus clindamycin afterudfailure of fi rst-line recommended ACT (QUINACT): a bicentre,udopen-label, phase 3, randomised controlled trial

机译：相同的治疗效果和安全性基于青蒿素的联合治疗（ACT）的比较 ud ud后使用其他ACT和奎宁加克林霉素治疗一线推荐ACT（QUINACT）失败：双中心， ud开放标签，第3期，随机对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Muhindo Mavoko Hypolite; Nabasumba Carolyn; Inocêncio da Luz Raquel; Tinto Halidou; D’Alessandro Umberto; Kambugu Andrew; Baraka Vito; Rosanas-Urgell Anna; Lutumba Pascal; Van geertruyden Jean-Pierre;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial [J] . Hypolite Muhindo Mavoko, Carolyn Nabasumba, Raquel Inocêncio da Luz, The Lancet Global Health . 2017,第1期

机译：与替代行为（ACT）相比，重新治疗的疗效和安全性与替代行为和奎宁加克林霉素在第一线推荐法案失败后（Quinact）：双门，开放标签，第3阶段，随机化受控试验
2. Effi cacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial [J] . Lenze Eric J., Mulsant Benoit H., Blumberger Daniel M., The Lancet . 2015,第10011期

机译：使用阿立哌唑增强药物治疗晚期生命中的抗抑郁药的疗效，安全性和耐受性：一项随机，双盲，安慰剂对照试验
3. Effi cacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): A multicentre, double-blind, placebo-controlled, randomised trial [J] . ImazioM., BelliR., BrucatoA., The Lancet . 2014,第9936期

机译：秋水仙碱对心包炎多发性复发（CORP-2）的疗效和安全性：一项多中心，双盲，安慰剂对照的随机试验
4. A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial [O] . Sobha Sivaprasad, Geoffrey Arden, A Toby Prevost, 2014

机译：一项多中心III期随机对照单掩盖临床试验评估了遮光膜在预防早期糖尿病性黄斑水肿（CLEOPATRA）中防止暗适应的临床疗效和安全性：一项随机对照试验的研究方案
5. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial [O] . Mavoko Hypolite Muhindo, Nabasumba Carolyn, da Luz Raquel Inocêncio, 2017

机译：一线推荐ACT（QUINACT）失败后，采用相同的基于青蒿素的联合治疗（ACT）与另一种ACT和奎宁加克林霉素进行再治疗的疗效和安全性：双中心，开放标签，第3期，随机对照试验

Effi cacy and safety of re-treatment with the sameudartemisinin-based combination treatment (ACT) comparedudwith an alternative ACT and quinine plus clindamycin afterudfailure of fi rst-line recommended ACT (QUINACT): a bicentre,udopen-label, phase 3, randomised controlled trial

著录项

相似文献

相关主题

期刊订阅